L’algue Klamath et ses propriétés nutritionnelles. Un extrait spécifique aux effets neuromodulateurs et neuroprotecteurs

详细信息    查看全文

• 作者：F. Joanny Menvielle-Bourg (1)
  A. Vitacca (1)
  S. Scoglio (2)
  
• 关键词：Microalgue Klamath ; Extrait spécifique breveté ; Profil nutritionnel complet et à haute biodisponibilité ; Action neuroprotectrice et neuromodulatrice ; Klamath microalgae ; Patented specific extract ; Complete and bioavalaible nutritionnal content ; Neuroprotective and neuromodulating action
• 刊名：Phytoth篓娄rapie
• 出版年：2011
• 出版时间：June 2011
• 年：2011
• 卷：9
• 期：3
• 页码：165-171
• 全文大小：1019KB
• 参考文献：1. Afssa Saisine n^oo2001-SA-0035a, avis Afssa relatif aux modalités d’application de l’article R. 1321-2 du Code de la santé publique concernant le contr?le sanitaire de la limite de qualité définie pour la microcystine-LR dans les eaux destinées à la consommation humaine
  2. Baroni L, Scoglio S, Benedetti S, et al. (2009) Effect of a Klamath algae product (“AFA-B12- on blood levels of vitamin B12 and homocysteine in vegan subjects: a pilot study. Int J Vitam Nutr Res 79(2): 117-23 CrossRef
  3. Bellingeri P, Scoglio S (2009) Complementary treatment of mood disorders associated with oncological diseases by using the Klamath algae (Aphanizomenon flos-aquae) extract Klamin?: a pilot study (en attente de publication)
  4. Benedetti S, Scoglio S (2003) Stato antiossidante e perossidazione lipidica in risposta alla supplementazione con alga Klamath. Medicina Naturale 6: 67-1
  5. Benedetti S, Scoglio S, Benvenuti F, et al. (2004) Antioxidant properties of a novel phycocyanin extract from the blue-green alga Aphanizomenon flos-aquae. Life Sci 75(19): 2353-362 CrossRef
  6. Benedetti S, Scoglio S, Benvenuti F, et al. (2010) Oxygen radical absorbance capacity of phycocyanin and phycocyanobilin from the food supplement Aphanizomenon flos-aquae. J Med Food 13(1): 223-27 CrossRef
  7. Benedetti S, Rinalducci S, Benvenuti F, et al. (2006) Purification and characterization of phycocyanin from the blue-green alga Aphanizomenon flos-aquae. J Chromatogr B Analyt Technol Biomed Life Sci 833(1): 12-8 CrossRef
  8. Benedetti Y (2007) Attività neuromodulatoria e neuroprotettiva della microalga Aphanizomenon flos-aquae, Università di Urbino, Facoltà di Scienze, Dottorato in Metodologie Biochimiche e Farmacologiche
  9. Berry MD (2007) The potential of trace amines and their receptors for treating neurological and psychiatric disorders. Rev Recent Clin Trials 2(1): 3-9 CrossRef
  10. Besler HT (2002) Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 5(3): 215-20 CrossRef
  11. Carmichael WW, Drapeau C, Anderson DM (2000) Harvesting and quality control of Aphanizomenon flos-aquae from Klamath lake for human dietary use. J Applied Phycology 12(6): 585-95 CrossRef
  12. Clark CR, Geffen GM, Geffen LB, et al. (1987) Catecholamines and attention I: animal and clinical studies. Neurosci Biobehav Rev Winter 11(4): 341-52 CrossRef
  13. Coppen A, Bolander-Gouaille C (2005) Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol 19(1): 59-5 CrossRef
  14. Document interne Klamath valley botanicals (KVB)-manufacturing process
  15. Document interne NUTRATEC-Klamath lake algae product specifications
  16. Genazzani AD, Chierchia E, Lanzoni C, et al. (2010) Effects of Klamath algae extract on psychological disorders and depression in menopausal women: a pilot study. Minerva Ginecol 62(5): 381-88
  17. Gonzales R, Rodríguez S, Romay C, et al. (1999) Anti-inflammatory activity of phycocyanin extract in acetic acid induced colitis in rats. Pharmacol Res 39(1): 55-9 CrossRef
  18. Goodman AB, Pardee AB (2003) Evidence for defective retinoid transport and function in late onset Alzheimer’s disease. Proc Natl Acad Sci U S A 100(5): 2901-905 CrossRef
  19. Hart AN, Zaske LA, Patterson KM, et al. (2007) Natural killer cell activation and modulation of chemokine receptor profile in vitro by an extract from the cyanophyta Aphanizomenon flos-aquae. J Med Food 10(3): 435-41 CrossRef
  20. Hoeger SH, Hitzfeld BC, Dietrich DR, et al. (2005) Occurrence and elimination of cyanobacterial toxins in drinking water treatment plants. Toxicology Appl Pharmacol 203: 231-42 CrossRef
  21. Jensen GS, Ginsberg DI, Huerta P, et al. (2000) Consumption of Aphanizomenon flos-aquae has rapid effects on the circulation and function of immune cells in humans. JANA 2(3): 50-8
  22. Kamat JP (2000) / Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta 1487(2-): 113-27
  23. Kelly A, Reynolds MSPH (2004) Cyanobacteria: natural organisms with toxic effects. Water Conditioning & Purification 78-0
  24. Les données concernant la composition nutritionnelle de la Klamath sont fournies par le centre de recherches nutrithérapiques d’Urbino (Italie) dirigé par le Docteur S Scoglio
  25. Lucca A, Catalano M, Scoglio S, et al. (2011) Complementary treatment of depressed patients undergoing pharmacological therapy with a natural product based on Klamath algae and its proprietary extract Klamin? (in press)
  26. Mecocci P (2004) Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J Alzheimers Dis 6(2):159-63
  27. Nagaoka S, Shimizu K, Kaneko H, et al. (2005) A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of spirulina platensis concentrate in rats. J Nutr 135(10): 2425-430
  28. Ozcan ME (2004) Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19(2): 89-5 CrossRef
  29. Rafail I (2000) Favorable effects of blue-green algae Aphanizomenon flos-aquae on rat plasma lipids. JANA 2(3): 59-5
  30. Reddy CM, Bhat VB, Kiranmai G, et al. (2000) Selective Inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem Biophys Res Commun 277(3): 599-03 CrossRef
  31. Rimbau V, Camins A, Romay C, et al. (1999) Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus. Neurosci Lett 276(2): 75-8 CrossRef
  32. Sabelli HC (1990) Urinary phenylacetic acid in panic disorder with and without depression. Acta Psychiatr Scand 82(1): 14-6 CrossRef
  33. Sabelli HC, Fawcett J, Gusovsky F, et al. (1986) Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry 47(2): 66-0
  34. Sabelli HC, Fink P, Fawcett J, et al. (1996) Sustained antidepressant effect of PEA replacement. J Neuropsychiatry Clin Neurosci Spring 8(2): 168-71
  35. Saker ML, Welker M, Vasconcelos VM (2007) Multiplex PCR for the detection of toxigenic cyanobacteria in dietary supplements produced for human consumption. Appl Microbiol Biotechnol 73(5):1136-142 (abstract) CrossRef
  36. Schaeffer DJ, Malpas PB, Barton LL, et al. (1999) Risk assessment of microcystins in dietary Aphanizomenon flos-aquae. Ecotoxicol Environmental Saf 44: 73-0 CrossRef
  37. Scoglio S (2006) Klamin?: a patented AFA extract, document du Centro Ricerche Nutriterapiche
  38. Scoglio S, Benedetti S, Canino C, et al. (2009) Effect of a 2-month treatment with Klamin?, a Klamath algae extract, on the general well-being,ntioxidant profile and oxidative status of postmenopausal women. Gynecological Endocrinol 25(4): 235-40 CrossRef
  39. Solanto MV (2002) Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130(1-): 65-1 CrossRef
  40. Tiemeier H, van Tuijl HR, Hofman A, et al. (2002) Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 159(12): 2099-101 CrossRef
  41. Tsuboi H, Shimoi K, Kinae N, et al. (2004) Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 56(1): 53-8 CrossRef
  42. Unger EL, Wiesinger JA, Hao L, et al. (2008) Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue. J Nutr 138(12): 2487-494 CrossRef
  43. Vadiraja BB, Gaikwad NW, Madyastha KM (1998) Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats. Biochem Biophys Res Commun 249(2): 428-31 CrossRef
  44. WO/2008/000430 (2008) Alphanizomenon flos aquae Preparation, Extracts And Purified Components Thereof For The Treatment Of Neurological, Neurodegenerative And Mood Disorders
  45. Wolters M, et al. (2004) Cobalamin: a critical vitamin in the elderly. Prev Med 39(6): 1256-266 CrossRef
  46. Hart AN, Zaske LA, Patterson KM, et al. (2007) Natural killer cell activation and modulation of chemokine receptor profile in vitro by an extract from the cyanophyta / Aphanizomenon flos-aquae. J Med Food 10(3):435-41 CrossRef
  
• 作者单位：F. Joanny Menvielle-Bourg (1)
  A. Vitacca (1)
  S. Scoglio (2)
  
  1. Fabienne Joanny Consulting & Licensing, Paris, France
  2. Centro Ricerche Nutriterapiche, Urbino, Italie
  

文摘

Klamath algae (Aphanizomenon flos-aquae [AFA] Ralfs ex Born. & Flah. Var. flos aquae), an unicellular microalgae living in the Klamath freshwater lake (USA), presents a very complete nutritional profile, with a very high bioavailabitlity level: 20 amino-acids, more than 60 minerals and trace elements, 14 vitamins, 15 carotenoids, chlorophyll, β-carotenes, omega-3 and omega-6 fatty acids, and algae specific molecules such as mycosporine-like aminoacids (MAAs) [algae mycosporins], AFA-phycocyanins (AFA-PCs), β-phenylethylamin (PEA). Research works performed by the Nutritherapeutic Research Centre (Urbino, Italy) in collaboration with the University of Urbino, allowed to develop a patented specific extract, with an important neuromodulating and neuroprotective action. The advantages of this extract, obtained via a mechanical extraction process without any chemical solvent (ultra-filtration), come from the synergistic action of PEA (β-PEA) with other microalgae molecules, especially AFA-phycocianins, AFA phytochromes and MAAs, who exert selective inhibiting effects on MAO-B and thus facilitate the action of PEA on the cerebral function. That specific extract contains a synergistic complex of molecules providing beneficial effects on the mental condition, contributing to prevent the ageing of neuronal functions.